Digestive problems including IBS are common, but a low FODMAP diet may be helpful for some sufferers. Research suggests there is a strong connection between symptoms such as gas, bloating, diarrhea, or constipation and FODMAPS.
FODMAP stands for Fermentable Oligo-Di-Mono-Saccharides and Polyols. Basically, this means short-chain carbohydrates which can be found in certain foods. Wheat and beans are an examples. Some people just can’t digest them, so gut bacteria use them as fuel, leading to all kinds of unpleasant symptoms.
Founded in February 2014, 4D Pharma (LON:DDDD) is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform that rationally identifies novel bacteria that have a precise and evolved therapeutic effect. All of 4D’s Live Biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut. 4D has completed a Phase I study in Irritable Bowel Syndrome and has completed dosing in a Phase I study in Paediatric Crohn’s Disease. It currently has a pipeline of 13 pre-clinical programmes, covering disease areas such as cancer, poorly controlled asthma, autoimmune and CNS disease, and plans to commence four additional clinical studies in 2018.